QQ客服 官方微博 反馈留言

	Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)
	Hu, C. S.; Chan, A.; Gao, L.; Ahn, M. -J.; Cohen, E.; Ang, M. -K.; Cheng, Y.; Hu, Q.; Kim, S. -B.; Li, P.
	2015
卷号	26
会议录	ANNALS OF ONCOLOGY
语种	英语
URL标识	查看原文
ISSN号	0923-7534
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/4643176
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Hu, C. S.,Chan, A.,Gao, L.,et al. Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)[C]. 见:.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。